XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basis of Presentation (Tables)
3 Months Ended
Mar. 31, 2024
Basis of Presentation [Abstract]  
Schedule of Diluted Loss per Share The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three months ended March 31, 2024 and 2023 because their effect was antidilutive:
Security  2024   2023 
         
Convertible notes payable   8,277    308,287 
Warrants   598,267    153,653 
Stock options   1,880,971    993,208 
    2,487,515    1,455,148 

 

Schedule of Deferred Contract Cost Activity The following table summarizes deferred contract cost activity for the three months ended March 31, 2024:
   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2023  $157,300 
Additions   5,850 
Amortization   (2,432)
Carrying Value at March 31, 2024  $160,718